155 related articles for article (PubMed ID: 17410330)
1. Metabolic deactivation of low-grade glioma during chemotherapy.
Roelcke U; Wyss M; Bärtschi E; Hofer S
J Neurol; 2007 May; 254(5):668-9. PubMed ID: 17410330
[No Abstract] [Full Text] [Related]
2. Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.
Kim MM; Lawrence TS; Cao Y
Semin Radiat Oncol; 2015 Jul; 25(3):172-80. PubMed ID: 26050587
[TBL] [Abstract][Full Text] [Related]
3. Low-grade Glioma, High Stakes Controversy-When and How to Treat in the Molecular Era?
Tom MC; Murphy ES
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):516-517. PubMed ID: 29893268
[No Abstract] [Full Text] [Related]
4. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
5. [Potential of PET in the diagnosis and the assessment of treatment effectiveness in progressive malignant glioma].
Kostenikov NA; Tiushin LA; Fadeev NP; Kartashev AV; Zykov EM; Golovtsova MIu
Vopr Onkol; 2011; 57(3):337-42. PubMed ID: 21882605
[TBL] [Abstract][Full Text] [Related]
6. ⁹⁰Y-based PET and SPECT/CT imaging in locoregional brain treatment for high-grade gliomas: retrospective fusion with MRI.
Fabbri C; Mattone V; Sarti G; Casi M; De Lauro F; Agostini M; Bartolini N; Bartolomei M
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1822-3. PubMed ID: 22872309
[No Abstract] [Full Text] [Related]
7. Persistent Nontumoral High-Amino-Acid Uptake on Brain [11C]Methionine PET/CT in a Patient After Combined Glioma Treatment.
Skvortsova TY; Savintceva ZI; Zhavoronkova AS; Gurchin AF; Andropova PL
Clin Nucl Med; 2021 Jul; 46(7):e376-e377. PubMed ID: 33661209
[TBL] [Abstract][Full Text] [Related]
8. Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data System.
Weinberg BD; Gore A; Shu HG; Olson JJ; Duszak R; Voloschin AD; Hoch MJ
J Am Coll Radiol; 2018 May; 15(5):767-771. PubMed ID: 29503151
[No Abstract] [Full Text] [Related]
9. PET imaging with p-[I-124]iodo-l-phenylalanine as a new tool for diagnosis and postoperative control in patients with glioma.
Farmakis G; Brandau W; Hellwig D; Wollenweber F; Schaefer A; Kirsch CM; Samnick S
Clin Nucl Med; 2008 Jun; 33(6):441-2. PubMed ID: 18496461
[No Abstract] [Full Text] [Related]
10. Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma.
Chung C; Metser U; Ménard C
Semin Radiat Oncol; 2015 Jul; 25(3):164-71. PubMed ID: 26050586
[TBL] [Abstract][Full Text] [Related]
11. The value of metabolic imaging in diagnosis and resection of cerebral gliomas.
Floeth FW; Stummer W
Nat Clin Pract Neurol; 2005 Dec; 1(2):62-3. PubMed ID: 16932494
[No Abstract] [Full Text] [Related]
12. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
13. Imaging of intratumoral heterogeneity in high-grade glioma.
Hu LS; Hawkins-Daarud A; Wang L; Li J; Swanson KR
Cancer Lett; 2020 May; 477():97-106. PubMed ID: 32112907
[TBL] [Abstract][Full Text] [Related]
14. The use of (18)F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma.
Dankbaar JW; Snijders TJ; Robe PA; Seute T; Eppinga W; Hendrikse J; De Keizer B
J Neurooncol; 2015 Oct; 125(1):167-75. PubMed ID: 26384811
[TBL] [Abstract][Full Text] [Related]
15. Amino Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist Needs to Know.
Soni N; Ora M; Jena A; Rana P; Mangla R; Ellika S; Almast J; Puri S; Meyers SP
AJNR Am J Neuroradiol; 2023 Mar; 44(3):236-246. PubMed ID: 36657945
[TBL] [Abstract][Full Text] [Related]
16. Striking a Chord? Not a Typical Low-Grade Glioma.
McDermott DM; Singh SA
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):518-519. PubMed ID: 32976779
[No Abstract] [Full Text] [Related]
17. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
[TBL] [Abstract][Full Text] [Related]
18. Glioma therapies: how to tell which work?
Perry JR; Cairncross JG
J Clin Oncol; 2003 Oct; 21(19):3547-9. PubMed ID: 12913102
[No Abstract] [Full Text] [Related]
19. Treatment of low-grade gliomas in children: an update.
Zacharoulis S; Kieran MW
Expert Rev Neurother; 2004 Nov; 4(6):1005-14. PubMed ID: 15853527
[TBL] [Abstract][Full Text] [Related]
20. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
